Search Results - "Mas Fontao, Sebastián"
-
1
Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice
Published in International journal of molecular sciences (02-04-2022)“…Metabolic associated fatty liver disease (MAFLD) is a hepatic manifestation of metabolic syndrome and usually associated with obesity and diabetes. Our aim is…”
Get full text
Journal Article -
2
Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice
Published in Frontiers in pharmacology (16-03-2022)“…Diabetic nephropathy (DN) is the main leading cause of chronic kidney disease worldwide. Although remarkable therapeutic advances have been made during the…”
Get full text
Journal Article -
3
One-year longitudinal association between changes in dietary choline or betaine intake and cardiometabolic variables in the PREvención con DIeta MEDiterránea-Plus (PREDIMED-Plus) trial
Published in The American journal of clinical nutrition (01-12-2022)“…Choline and betaine intakes have been related to cardiovascular health. We aimed to explore the relation between 1-y changes in dietary intake of choline or…”
Get full text
Journal Article -
4
Intravascular hemolysis triggers NAFLD characterized by a deregulation of lipid metabolism and lipophagy blockade
Published in The Journal of pathology (01-10-2023)“…Intravascular hemolysis is a common feature of different clinical entities, including sickle cell disease and malaria. Chronic hemolytic disorders are…”
Get full text
Journal Article -
5
Alpha‐klotho and peritoneal membrane status: A hypothesis generating study
Published in European journal of clinical investigation (01-03-2023)“…Background Long‐term success of peritoneal dialysis relies on the integrity of the peritoneal membrane. This proof‐of‐concept study addressed the hypothesis…”
Get full text
Journal Article -
6
P-2 DE NOVO LIPOGENESIS MARKERS ARE INVOLVED IN METABOLIC ASSOCIATED FATTY LIVER DISEASE PROGRESSION IN BTBR OB/OB MICE
Published in Annals of hepatology (01-03-2023)“…The new recommendations suggesting changing the current nomenclature from Non-Alcoholic Fatty Liver Disease (NAFLD) to Metabolic associated fatty liver disease…”
Get full text
Journal Article -
7
Displacing the Burden: A Review of Protein-Bound Uremic Toxin Clearance Strategies in Chronic Kidney Disease
Published in Journal of clinical medicine (01-03-2024)“…Uremic toxins (UTs), particularly protein-bound uremic toxins (PBUTs), accumulate in chronic kidney disease (CKD) patients, causing significant health…”
Get full text
Journal Article -
8
Reactions to Synthetic Membranes Dialyzers: Is there an Increase in Incidence?
Published in Kidney & blood pressure research (01-10-2019)“…Abstract Background: Reactions to dialyzers used in dialysis have been reported more frequently in recent years. Evidence, however, shows that the reaction…”
Get full text
Journal Article -
9
Bisphenol A in renal insufficiency: how long will it be used? Is it time to avoid it?
Published in Nefrología (01-05-2024)Get full text
Journal Article -
10
Bisfenol A en la insuficiencia renal: ¿hasta cuándo se podrá usar? ¿Es la hora de evitarlo?
Published in Nefrología (01-05-2024)Get full text
Journal Article -
11
Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease
Published in International journal of molecular sciences (01-03-2024)“…Metabolic-dysfunction-associated steatotic liver disease (MASLD) is a prevalent clinical condition associated with elevated morbidity and mortality rates…”
Get full text
Journal Article -
12
Sarcopenia assessed by 4-step EWGSOP2 in elderly hemodialysis patients: Feasibility and limitations
Published in PloS one (13-01-2022)“…In 2019, EWGSOP2 proposed 4 steps to diagnose and assess sarcopenia. We aimed to quantify the prevalence of sarcopenia according to the EWGSOP2 diagnostic…”
Get full text
Journal Article -
13
Fibrosis of Peritoneal Membrane, Molecular Indicators of Aging and Frailty Unveil Vulnerable Patients in Long-Term Peritoneal Dialysis
Published in International journal of molecular sciences (01-03-2023)“…Peritoneal membrane status, clinical data and aging-related molecules were investigated as predictors of long-term peritoneal dialysis (PD) outcomes. A 5-year…”
Get full text
Journal Article -
14
Sarcopenia and Mortality in Older Hemodialysis Patients
Published in Nutrients (05-06-2022)“…(1) Sarcopenia is a progressive loss of skeletal muscle mass and strength. The aim of this study was to determine the association of sarcopenia, defined…”
Get full text
Journal Article -
15
Dependency and frailty in the older haemodialysis patient
Published in BMC geriatrics (10-05-2024)“…Frailty among older adults undergoing hemodialysis is increasingly prevalent, significantly impacting cognitive function, mobility, and social engagement. This…”
Get full text
Journal Article -
16
Clinical Features of Asymptomatic SARS-CoV-2 Infection in Hemodialysis Patients
Published in Kidney & blood pressure research (01-02-2021)“…Background: CKD is a risk factor for severe COVID-19. However, the clinical spectrum of COVID-19 in hemodialysis patients is still poorly characterized…”
Get full text
Journal Article -
17
Definition and evolution of the concept of sarcopenia
Published in Nefrología (01-05-2024)“…Sarcopenia and dynapenia are two terms associated with ageing that respectively define the loss of muscle mass and strength. In 2018, the European Working…”
Get full text
Journal Article -
18
Adherence to an Energy-restricted Mediterranean Diet Score and Prevalence of Cardiovascular Risk Factors in the PREDIMED-Plus: A Cross-sectional Study
Published in Revista española de cardiología (English ed.) (01-11-2019)“…Abstract Introduction and objectives The cardiovascular benefits of the Mediterranean diet have usually been assessed under assumptions of ad libitum total…”
Get full text
Journal Article -
19
Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial
Published in Journal of clinical medicine (03-03-2023)“…To compare the effect of glucose-lowering drugs on peripheral nerve and kidney function in prediabetes. Multicenter, randomized, placebo-controlled trial in…”
Get full text
Journal Article -
20
Oxidative stress and inflammation on metabolic abnormalities and renal involvement in prediabetic subjects across Europe
Published in Nefrología (01-10-2024)Get full text
Journal Article